Zhendong Pharmaceutical shouted 'my sales have not increased significantly', and there is no one willing to wait

On December 13, Zhendong Pharmaceutical closed with a 20.00% price limit and attracted the main capital of 242.08 million to enter the market, which can be described as the limelight.

Closely related to this surge are two of its products that have attracted attention, one is Yinqiao detoxification capsules, and the other is Huo Xiang zhengqi capsules. Of course, as for whether the sales volume has increased greatly, the company has not responded to Huo Xiang Zhengqi capsules. However, it said that the sales of Banlangen granules and Yinqiao detoxification capsules did not increase significantly.

After going to the pharmacy to buy medicine last night, I did find that Yinqiao Detoxification Capsules and Huo Xiang Zhengqi Capsules were promoted by store staff. After all, Lianhua Qingwen has a daily sales of 400,000 yuan in pharmacies, and many products want to learn how to better serve health. After not being able to buy those hot-selling products, some consumers will turn to the formula to see which drugs have similar formula components, so that many of the ones in stock will be promoted. For example, I didn't buy ibuprofen last night, so I bought back Xiao Chai Hu granules, because there is a friend who is an otolaryngologist, and at the critical moment, the choice of profession must be respected.

Since the release of ibuprofen sales, Xinhua Pharmaceutical has steadily achieved the rise of the stock, with six limit increases in seven days. Although the main funds are flowing out, they still can't stop this impulse again and again, and as for when the impulsive punishment will come, they can't care so much.

For the popularity of ibuprofen, the reason why the market has not decreased is because of the shortage of stocks in the market. Confirms the phrase in the crosstalk, "I'm sick, do you have medicine?" How much I eat! "Some hospitals have imposed restrictions on the number of ibuprofen purchased by medical staff, opening up to one or two boxes a week, and some have even been unable to guarantee the normal supply of medicines.

Do you know what is the most anxious thing in stocking? I don't know when the deadline is the point. When preparing food in the past, some friends looked at the full refrigerator and complained, "Should I let go of eating, or should I consume it slowly?" "Because there is no time prompt, no one dares to consume wantonly. And ibuprofen is such a state, and other cold medicines are also in this situation. And according to the scene, the sales of proprietary Chinese medicines also account for a high proportion.

This is in line with the previous market structure division, as far as the epidemic is concerned, the layout of domestic cold medicine, always the proportion of traditional Chinese medicine is higher. It is about twice as much as Western medicine, which may be related to the variety of traditional Chinese medicine and the experience of use.

But the competition of cold medicine is not that domestic companies have more advantages. The top ten market shares can account for more than half of the whole, and are mainly foreign capital, and domestic large pharmaceutical companies have a catch-up trend.

However, some small pharmaceutical companies have limited competitive advantages, or are limited to raw materials, or limited to channels, or limited to external policies tend to be strict, and their survival is not good. There have even been cases of being recalled due to the purchase of extracts of Chinese medicine components, probably because the cost of preparing Chinese medicine extracts by themselves is unacceptable or the process is not easy.

These status quos restrict small cold medicine companies, and also make the head companies have a deeper control over their market share. In the middle and late stages of the epidemic, it is a test of the smooth flow of channels. Some companies have goods and may not be able to quickly enter pharmacies to sell. Some pharmacies are out of stock, but they have to wait for the supply of partner brands. In the end, the strong are stronger, and the market keeps going up.

Zhendong Pharmaceutical's wave of growth is a typical hero of the times, and the blessing of traditional Chinese medicine plus new crown and cold may become a value-added period similar to Guizhou Bailing and Xinhua Pharmaceutical. But how long this period can last depends not on capital, but on whether the sales of drugs can be opened, otherwise it will be another wave.